 |
|
|
| |
No Pharmacokinetic Interaction Between HCV Inhibitors
Grazoprevir/Elbasvir with Rilpivirine
|
| |
| |
Clinical Pharm of HIV & Hepatitis Drug-Drug Interactions with Grazoprevir/Elbasvir: Practical Considerations for the Care of HIV/HCV Co-Infected Patients - (06/03/15)
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, May 26 - May 28, 2015, Washington DC.
Wendy W. Yeh1, Hwa-Ping Feng1, Patrice Auger2, Zifang Guo1, Luzelena Caro1, Daria Stypinski2, John Brejda2, Patricia Jumes1, Barbara Cook2, William L. Marshall1, Marian Iwamoto1, Joan R. Butterton1
1Merck & Co., Inc., Kenilworth, NJ, USA, 2 Celerion, Lincoln, NE, USA
|
| |
|
|
|
|
|
